sacituzumab govitecan
gilead sciences
['beat', 'trodelvy', 'breast', 'biotec']
sfbn feed: #asco22: gilead s trodelvy shows slim benefit in common form of breast cancer: in march, gilead drew ire from analysts for releasing an upbeat q&amp;a without any hard data for its latest trodelvy ... #bayarea #biotech 
San Francisco Biotechnology News and Events, follow jobs at @sfbnjobs